Enteral Nutrition Drug - Global and China Top Players Market Share and Ranking 2023

Tables and Figures

Table 1. Enteral Nutrition Drug Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Enteral Nutrition Drug Market Restraints
Table 3. Enteral Nutrition Drug Market Trends
Table 4. Enteral Nutrition Drug Industry Policy
Table 5. Global Enteral Nutrition Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Enteral Nutrition Drug Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Enteral Nutrition Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Enteral Nutrition Drug Mergers & Acquisitions, Expansion Plans
Table 9. Global Enteral Nutrition Drug Major Companies Product Type
Table 10. Head Office and Area Served of Key Players
Table 11. China Enteral Nutrition Drug Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 12. China Enteral Nutrition Drug Revenue Market Share by Company, 2018-2023
Table 13. Global Key Players of Enteral Nutrition Drug Upstream (Raw Materials)
Table 14. Global Enteral Nutrition Drug Typical Customers
Table 15. Enteral Nutrition Drug Typical Distributors
Table 16. By Type, Global Enteral Nutrition Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Application, Global Enteral Nutrition Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Enteral Nutrition Drug Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 19. By Region, Global Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Table 20. By Country, Global Enteral Nutrition Drug Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 21. By Country, Global Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Table 22. By Country, Global Enteral Nutrition Drug Consumption Value Market Share, 2018-2029
Table 23. Hospira Inc Company Information, Head Office, Market Area and Industry Position
Table 24. Hospira Inc Company Profile and Main Business
Table 25. Hospira Inc Enteral Nutrition Drug Models, Specifications, and Application
Table 26. Hospira Inc Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 27. Hospira Inc Recent Developments
Table 28. Fresenius Kabi Company Information, Head Office, Market Area and Industry Position
Table 29. Fresenius Kabi Company Profile and Main Business
Table 30. Fresenius Kabi Enteral Nutrition Drug Models, Specifications, and Application
Table 31. Fresenius Kabi Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 32. Fresenius Kabi Recent Developments
Table 33. Danone Company Information, Head Office, Market Area and Industry Position
Table 34. Danone Company Profile and Main Business
Table 35. Danone Enteral Nutrition Drug Models, Specifications, and Application
Table 36. Danone Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 37. Danone Recent Developments
Table 38. Knowmedical Company Information, Head Office, Market Area and Industry Position
Table 39. Knowmedical Company Profile and Main Business
Table 40. Knowmedical Enteral Nutrition Drug Models, Specifications, and Application
Table 41. Knowmedical Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 42. Knowmedical Recent Developments
Table 43. Nestlé Company Information, Head Office, Market Area and Industry Position
Table 44. Nestlé Company Profile and Main Business
Table 45. Nestlé Enteral Nutrition Drug Models, Specifications, and Application
Table 46. Nestlé Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 47. Nestlé Recent Developments
Table 48. B. Braun Melsungen AG Company Information, Head Office, Market Area and Industry Position
Table 49. B. Braun Melsungen AG Company Profile and Main Business
Table 50. B. Braun Melsungen AG Enteral Nutrition Drug Models, Specifications, and Application
Table 51. B. Braun Melsungen AG Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 52. B. Braun Melsungen AG Recent Developments
Table 53. Abbott Company Information, Head Office, Market Area and Industry Position
Table 54. Abbott Company Profile and Main Business
Table 55. Abbott Enteral Nutrition Drug Models, Specifications, and Application
Table 56. Abbott Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 57. Abbott Recent Developments
Table 58. Otsuka Pharmaceutical India Private Limited Company Information, Head Office, Market Area and Industry Position
Table 59. Otsuka Pharmaceutical India Private Limited Company Profile and Main Business
Table 60. Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Models, Specifications, and Application
Table 61. Otsuka Pharmaceutical India Private Limited Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 62. Otsuka Pharmaceutical India Private Limited Recent Developments
Table 63. NUTRICHEM DIÄT + PHARMA GMBH Company Information, Head Office, Market Area and Industry Position
Table 64. NUTRICHEM DIÄT + PHARMA GMBH Company Profile and Main Business
Table 65. NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Models, Specifications, and Application
Table 66. NUTRICHEM DIÄT + PHARMA GMBH Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 67. NUTRICHEM DIÄT + PHARMA GMBH Recent Developments
Table 68. Delta Drugs Company Information, Head Office, Market Area and Industry Position
Table 69. Delta Drugs Company Profile and Main Business
Table 70. Delta Drugs Enteral Nutrition Drug Models, Specifications, and Application
Table 71. Delta Drugs Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 72. Delta Drugs Recent Developments
Table 73. Baxter Company Information, Head Office, Market Area and Industry Position
Table 74. Baxter Company Profile and Main Business
Table 75. Baxter Enteral Nutrition Drug Models, Specifications, and Application
Table 76. Baxter Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 77. Baxter Recent Developments
Table 78. Allergan Company Information, Head Office, Market Area and Industry Position
Table 79. Allergan Company Profile and Main Business
Table 80. Allergan Enteral Nutrition Drug Models, Specifications, and Application
Table 81. Allergan Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 82. Allergan Recent Developments
Table 83. Actavis Inc. Company Information, Head Office, Market Area and Industry Position
Table 84. Actavis Inc. Company Profile and Main Business
Table 85. Actavis Inc. Enteral Nutrition Drug Models, Specifications, and Application
Table 86. Actavis Inc. Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 87. Actavis Inc. Recent Developments
Table 88. Grifols, S.A. Company Information, Head Office, Market Area and Industry Position
Table 89. Grifols, S.A. Company Profile and Main Business
Table 90. Grifols, S.A. Enteral Nutrition Drug Models, Specifications, and Application
Table 91. Grifols, S.A. Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 92. Grifols, S.A. Recent Developments
Table 93. Vifor Pharma Company Information, Head Office, Market Area and Industry Position
Table 94. Vifor Pharma Company Profile and Main Business
Table 95. Vifor Pharma Enteral Nutrition Drug Models, Specifications, and Application
Table 96. Vifor Pharma Enteral Nutrition Drug Revenue and Gross Margin, US$ Million, 2018-2023
Table 97. Vifor Pharma Recent Developments
List of Figures
Figure 1. Enteral Nutrition Drug Picture
Figure 2. Global Enteral Nutrition Drug Consumption Value, (US$ million) & (2018-2029)
Figure 3. China Enteral Nutrition Drug Consumption Value, (US$ million) & (2018-2029)
Figure 4. By Consumption Value, China Enteral Nutrition Drug Market Share of Global, 2018-2029
Figure 5. Global Enteral Nutrition Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 6. China Enteral Nutrition Drug Key Participants, Market Share, 2022
Figure 7. Enteral Nutrition Drug Industry Chain
Figure 8. Enteral Nutrition Drug Procurement Model
Figure 9. Enteral Nutrition Drug Sales Model
Figure 10. Enteral Nutrition Drug Sales Channels, Direct Sales, and Distribution
Figure 11. Adults
Figure 12. Children
Figure 13. By Type, Global Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 14. By Type, Global Enteral Nutrition Drug Consumption Value Market Share, 2018-2029
Figure 15. Hospitals
Figure 16. Clinics
Figure 17. Pharmaceutical Companies
Figure 18. Others
Figure 19. By Application, Global Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 20. By Application, Global Enteral Nutrition Drug Consumption Value Market Share, 2018-2029
Figure 21. By Region, Global Enteral Nutrition Drug Consumption Value Market Share, 2018-2029
Figure 22. North America Enteral Nutrition Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 23. By Country, North America Enteral Nutrition Drug Consumption Value Market Share, 2022
Figure 24. Europe Enteral Nutrition Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 25. By Country, Europe Enteral Nutrition Drug Consumption Value Market Share, 2022
Figure 26. Asia Pacific Enteral Nutrition Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 27. By Country/Region, Asia Pacific Enteral Nutrition Drug Consumption Value Market Share, 2022
Figure 28. South America Enteral Nutrition Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 29. By Country, South America Enteral Nutrition Drug Consumption Value Market Share, 2022
Figure 30. Middle East & Africa Enteral Nutrition Drug Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 31. U.S. Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 32. By Type, U.S. Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 33. By Application, U.S. Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 34. Europe Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 35. By Type, Europe Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 36. By Application, Europe Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 37. China Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 38. By Type, China Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 39. By Application, China Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 40. Japan Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 41. By Type, Japan Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 42. By Application, Japan Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 43. South Korea Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 44. By Type, South Korea Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 45. By Application, South Korea Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 46. Southeast Asia Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 47. By Type, Southeast Asia Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 48. By Application, Southeast Asia Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 49. India Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 50. By Type, India Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 51. By Application, India Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 52. Middle East & Africa Enteral Nutrition Drug Consumption Value, 2018-2029, US$ Million
Figure 53. By Type, Middle East & Africa Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 54. By Application, Middle East & Africa Enteral Nutrition Drug Consumption Value Market Share, 2022 VS 2029
Figure 55. Research Methodology
Figure 56. Breakdown of Primary Interviews
Figure 57. Bottom-up and Top-down Approaches
Figure 58. Top-down Approaches

Reason to Buy

• Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
• Highlights key business priorities in order to assist companies to realign their business strategies
• The segment that is expected to dominate the Pharma & Healthcare Market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets